Stock SHILPAMED SHILPA MEDICARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Shilpa Medicare Limited NSE India S.E.

Equities

SHILPAMED

INE790G01031

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 05:17:10 2024-04-25 am EDT 		5-day change 1st Jan Change
530 INR -0.21% Intraday chart for Shilpa Medicare Limited +1.06% +60.46%
Apr. 18 Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US MT
Apr. 17 Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit MT

Business Summary

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in research and development, manufacturing and sale of oncology drugs and formulations. Its products consist of oncology and non-oncology active pharmaceutical ingredients (APIs), oncology formulations, biosimilars, ophthalmic, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales and transdermal patches. It supplies oncology APIs and intermediates. Its oncology/non-oncology APIs include Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib HCL, and Irinotecan HCL Trihydrate for various regulated markets, including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-oncology APIs products include Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India. It is also engaged in manufacturing and sale of Lenvatinib Capsules under the brand name Lenshil.

Number of employees: 1,179

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical Product and Services
99.2 %
11,354 99.1 % 10,415 99.2 % -8.27%
Others
0.6 %
55 0.5 % 67 0.6 % +21.79%
Power
0.2 %
46 0.4 % 19 0.2 % -58.53%

Sales per region

INR in Million2022Weight2023Weight Delta
India
48.6 %
4,880 42.6 % 5,106 48.6 % +4.62%
Europe
20.3 %
3,252 28.4 % 2,131 20.3 % -34.46%
United States
15.6 %
1,910 16.7 % 1,639 15.6 % -14.16%
Rest of World
15.5 %
1,414 12.3 % 1,625 15.5 % +14.94%

Managers

Managers TitleAgeSince
Vishnukanth Bhutada Chaturbhuj CEO
 Chief Executive Officer 63 87-11-19
Alpesh Dalal DFI
 Director of Finance/CFO - 21-05-30
Ganeshchandra Sonavane CTO
 Chief Tech/Sci/R&D Officer - -
Krishnappayya Desai CMP
 Compliance Officer - 22-03-15
Sharath Reddy Kalakota COO
 Chief Operating Officer 58 91-05-31
Ritu Tiwary CMP
 Compliance Officer 47 22-05-22
R. K. Somani PRN
 Corporate Officer/Principal - -
Awez Pathan PRN
 Corporate Officer/Principal 55 -
Seshachalam Unnam PRN
 Corporate Officer/Principal 59 08-01-02
Rajyashri Karur Ramakrishnan PRN
 Corporate Officer/Principal 60 17-12-31

Members of the board

Members of the board TitleAgeSince
Vishnukanth Bhutada Chaturbhuj CEO
 Chief Executive Officer 63 87-11-19
Hetal Madhukant Gandhi BRD
 Director/Board Member 58 21-09-01
Arvind Vasudeva BRD
 Director/Board Member 63 21-09-01
Kamal Kishore Sharma BRD
 Director/Board Member 76 22-06-30
Omprakash Tulsiram Inani CHM
 Chairman 67 88-03-22
Sharath Reddy Kalakota COO
 Chief Operating Officer 58 91-05-31
Anita Bandyopadhyay BRD
 Director/Board Member 55 22-08-10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 97,790,908 38,408,541 ( 39.28 %) 0 39.28 %

Shareholders

NameEquities%Valuation
Vishnukanth Bhutada Chaturbhuj
7.333 %
6,365,610 7.333 % 35 M ₹
Dharmavati Bhutada
7.152 %
6,207,796 7.152 % 34 M ₹
Ravi Inani
4.616 %
4,006,370 4.616 % 22 M ₹
Suraj Kumar Inani
4.586 %
3,980,695 4.586 % 22 M ₹
Ta Fii Investors Ltd.
3.485 %
3,025,000 3.485 % 17 M ₹
Omprakash Tulsiram Inani
3.304 %
2,867,691 3.304 % 16 M ₹
Deepak Kumar Inani
3.150 %
2,733,960 3.150 % 15 M ₹
Kanta Devi Inani
2.926 %
2,540,096 2.926 % 14 M ₹
Pivotal Enterprises Pvt Ltd.
2.535 %
2,200,000 2.535 % 12 M ₹
Keshav Bhutada
2.304 %
2,000,000 2.304 % 11 M ₹

Company contact information

Shilpa Medicare Ltd.

Shilpa House Hyderabad Road

584135, Raichur

+91 85 3223 8704

http://www.vbshilpa.com
address Shilpa Medicare Limited(SHILPAMED)

Group companies

NameCategory and Sector
FTF Pharma Pvt Ltd.
Logo FTF Pharma Pvt Ltd.

FTF Pharma Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

FTF Pharma Pvt Ltd. engages in the provision of pharmaceutical services. It offers identification of products, regulatory strategy, non-infringing and IP strategy, and bioequivalence and clinical trials. The company was founded by Jayanta Kumar Mandal on June 20, 2012 and is headquartered in Ahmedabad, India.

Pharmaceuticals: Major
Shilpa Biocare Pvt Ltd.
Shilpa Pharma Lifesciences Ltd.
Logo Shilpa Pharma Lifesciences Ltd.

Shilpa Pharma Lifesciences Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Shilpa Medicare Ltd., Shilpa Pharma Lifesciences Ltd. is an Indian company that manufactures pharmaceutical products. The private company is based in Raichur, India. The company was founded in 2020. Santosh Kumar Mahil has been the CEO of the company since 2024.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.61% 660B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.04% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.24% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.49% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.28% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.51% 219B
ROCHE HOLDING AG Stock Roche Holding AG
-9.82% 196B
NOVARTIS AG Stock Novartis AG
+6.81% 199B
PFIZER, INC. Stock Pfizer, Inc.
-8.75% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SHILPAMED Stock
  4. SHILPAMED Stock
  5. Company Shilpa Medicare Limited